Log In
BCIQ
Print this Print this
 

Photoreceptor progenitor cell therapy

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionPhotoreceptor progenitor cell
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$379.0M

$379.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/10/2016

$379.0M

$379.0M

0

03/24/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today